Biopharma contract manufacturing market continues to expand, expected to grow 8% over the next five years Read More >
Moving forward clinical studies will have to include a comparative assessment of
pharmacokinetics and immunogenicity to the original reference biologic drug Read More >
PCI execs talk about the recent opening of the company’s new North American clinical facility, as well as other trends in the market Read More >
More than $60 billion worth of patents on biological products are expiring before 2020, representing a major opportunity for the pharmaceutical industry. Read More >
As the demands that are being placed on the quality and stability of medications continue to increase, the interactions that take place between the primary packaging container and filled drug product are becoming increasingly important Read More >
We exceed expectations
Welcome to Contract Pharma’s Sixteenth Annual Salary Survey!
Summary from the 12th Annual Report and Summary of Biopharmaceutical Manufacturing Capacity and Production
(Based on 2014 Sales, in $U.S. Millions)
Herein are the results of our 2015 Annual Outsourcing Survey, where we call on you, the readers.
Thursday, July 23rd, 2 pm EST
The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.